Tablet Lonart DS

Lonart is a fixed-dose combination antimalarial containing Artemether and Lumefantrine. It is indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria and is one of the widely used artemisinin-based combination therapies (ACTs). It is not used for malaria prevention or severe malaria.

Rating: ★★★★☆ (4.8/5)

Strengths

• Fast relief of malaria symptoms, often within 24–48 hours.
• High cure rates when taken correctly with all six doses over three days.
• WHO-recommended ACT principle reduces parasite resistance.
• Suitable for adults and children (with weight-based dosing).
• Generally well tolerated with a good safety profile. 

Limitations

• Must be taken with food (preferably fatty food or milk) to improve absorption.
• Completing the full course is essential even if symptoms improve.
• Not suitable for severe malaria requiring injectable treatment.
• Should be used cautiously with medicines that prolong the QT interval or interact with CYP3A4. 

Common Side Effects

• Headache
• Dizziness
• Loss of appetite
• Nausea or vomiting
• Muscle or joint pain
• Weakness

These are usually mild and temporary.